How close are we to customizing chemotherapy in early non-small cell lung cancer?
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 4, p. 185, doi. 10.1177/1758834011409973
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2011 AND VI 3 AND IP 4
Results: 4
1
2
Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 4, p. 163, doi. 10.1177/1758834011409096
- By:
- Publication type:
- Article
3
Customizing systemic therapy in patients with advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 4, p. 207, doi. 10.1177/1758834011409000
- By:
- Publication type:
- Article
4
The role of the c-Met pathway in lung cancer and the potential for targeted therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 4, p. 171, doi. 10.1177/1758834011408636
- By:
- Publication type:
- Article